Use of pentoxifyllin in the treatment of multiple sclerosis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/52 (2006.01) A61K 31/56 (2006.01) A61K 31/57 (2006.01)

Patent

CA 2176848

The present invention relates to the use of pentoxy- phylline in treating both intermittently or chronically progressing forms of multiple sclerosis. It can be used either alone or in combination with corticosteroids. Irrespective of whether corticosteroids are present, the dosage is 0.01 to 6.0 g/day.

L'invention concerne l'utilisation de la pentoxyfylline dans le traitement de la sclérose en plaques évoluant par poussées successives ou progressivement de manière chronique. Cette substance peut s'utiliser seule ou en combinaison avec des corticostéroïdes, à raison de 0,01 à 6,0 g/jour, indépendamment de l'éventuelle présence de corticostéroïdes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of pentoxifyllin in the treatment of multiple sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of pentoxifyllin in the treatment of multiple sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of pentoxifyllin in the treatment of multiple sclerosis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1363658

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.